Short answer
HCA Healthcare (HCA) filed an 8-K current report with the SEC on July 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026.
HCA Healthcare 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Press release issued July 24, 2026
- Detailed operating results in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- HCA disclosed second-quarter 2026 operating results for the period ended June 30, 2026
- Market-relevant financial details are contained in Exhibit 99.1 accompanying the July 24, 2026 press release
Item 8.01 · Other Events
- Quarterly cash dividend of $0.78 per common share declared
- Payment scheduled for September 30, 2026
- September 16, 2026 record date determines eligible shareholders
- Recurring dividend supports shareholder income and signals continued capital-return commitment
Item EX-99.1 · Exhibit EX-99.1
- 2Q revenue rose 8.7% to $20.230B; diluted EPS increased 11.6% to $7.62 despite payer-mix pressure
- Uninsured patients reduced pretax income approximately $400M; exchange-related headwind estimate widened to $1.000B–$1.200B for 2026
- Medicaid supplemental payments provided approximately $400M incremental net benefit, primarily from Florida
- 2026 guidance narrowed lower: revenue $77.000B–$79.500B, EPS $28.70–$30.50, Adjusted EBITDA $15.400B–$16.100B
- Cash flow weakened to $2.335B while debt reached $49.718B; HCA repurchased $2.064B of shares in 2Q
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HCA Healthcare 8-K filings
Get the next HCA 8-K as it lands
Follow HCA for push alerts, or ask the research agent what this filing means.